News | January 06, 2024
Supriya Lifesciences received GMP certification from ANVISA Brazil
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
Employer-sponsored health insurance costs in India are expected to rise by 11% in 2024
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
Sarclisa added to bortezomib, lenalidomide and dexamethasone (VRd) significantly reduced the risk of disease progression or death compared with VRd alone
The companies will work with investigators to share the results with the scientific community
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
Our collaboration with MediSage to present 'Current Approaches to Uro-Oncology' embodies a crucial stride towards comprehensive cancer care
Six engaging sessions focusing on Prevention of Kidney Diseases, Brain Stem Death Declaration, Deceased Donor Management, Prevention of Liver Diseases, Legal Aspects of Organ and Tissue Donation, Eye Donation and Corneal Transplant held as part of the Webinar
The booster vaccine can be administered safely to individuals who have received two doses of either Covaxin or Covishield
Suven Life Sciences completed enrollment of patients to the phase-2, PoC clinical study of samelisant (SUVN-G3031) for the treatment of narcolepsy with or without cataplexy in USA and Canada
Subscribe To Our Newsletter & Stay Updated
